Legis Daily

To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.

USA115th CongressHR-4138| House 
| Updated: 10/27/2017
Elijah E. Cummings

Elijah E. Cummings

Democratic Representative

Maryland

Cosponsors (21)
Marcy Kaptur (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)Brian Higgins (Democratic)Carol Shea-Porter (Democratic)Steve Cohen (Democratic)Rosa L. DeLauro (Democratic)Ro Khanna (Democratic)Sean Patrick Maloney (Democratic)Keith Ellison (Democratic)Raja Krishnamoorthi (Democratic)Jerrold Nadler (Democratic)Pramila Jayapal (Democratic)Eleanor Holmes Norton (Democratic)Tulsi Gabbard (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Beto O'Rourke (Democratic)Peter Welch (Democratic)Suzanne Bonamici (Democratic)Lloyd Doggett (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicare Drug Price Negotiation Act This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans, including requirements relating to rebates for low-income individuals and drug price negotiations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 25, 2017

Latest Companion Bill Action

S 115-2011
Introduced in Senate
Oct 26, 2017
Introduced in House
Oct 26, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 27, 2017
Referred to the Subcommittee on Health.
  • October 25, 2017

    Latest Companion Bill Action

    S 115-2011
    Introduced in Senate


  • October 26, 2017
    Introduced in House


  • October 26, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 27, 2017
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 115-2011: A bill to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.
  • S 115-252: A bill to amend title XVIII of the Social Security Act to require drug manufacturers to provide drug rebates for drugs dispensed to low-income individuals under the Medicare prescription drug benefit program.
Congressional oversightGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceInflation and pricesMedicaidMedicarePrescription drugsPublic contracts and procurementRetail and wholesale trades

To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.

USA115th CongressHR-4138| House 
| Updated: 10/27/2017
Medicare Drug Price Negotiation Act This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans, including requirements relating to rebates for low-income individuals and drug price negotiations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 25, 2017

Latest Companion Bill Action

S 115-2011
Introduced in Senate
Oct 26, 2017
Introduced in House
Oct 26, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 27, 2017
Referred to the Subcommittee on Health.
  • October 25, 2017

    Latest Companion Bill Action

    S 115-2011
    Introduced in Senate


  • October 26, 2017
    Introduced in House


  • October 26, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 27, 2017
    Referred to the Subcommittee on Health.
Elijah E. Cummings

Elijah E. Cummings

Democratic Representative

Maryland

Cosponsors (21)
Marcy Kaptur (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)Brian Higgins (Democratic)Carol Shea-Porter (Democratic)Steve Cohen (Democratic)Rosa L. DeLauro (Democratic)Ro Khanna (Democratic)Sean Patrick Maloney (Democratic)Keith Ellison (Democratic)Raja Krishnamoorthi (Democratic)Jerrold Nadler (Democratic)Pramila Jayapal (Democratic)Eleanor Holmes Norton (Democratic)Tulsi Gabbard (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Beto O'Rourke (Democratic)Peter Welch (Democratic)Suzanne Bonamici (Democratic)Lloyd Doggett (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 115-2011: A bill to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.
  • S 115-252: A bill to amend title XVIII of the Social Security Act to require drug manufacturers to provide drug rebates for drugs dispensed to low-income individuals under the Medicare prescription drug benefit program.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceInflation and pricesMedicaidMedicarePrescription drugsPublic contracts and procurementRetail and wholesale trades